Response to Giannelli et al.--comments on potential efficacy of monthly administrations of spot-on moxidectin 2.5%/imidacloprid 10% in the simultaneous prevention of major canine filarioses.

Authors :: Traversa D
Famigli Bergamini P
Fracassi F
Pampurini F
Boari A
Source :: Parasitology research [Parasitol Res] 2014 Mar; Vol. 113 (3), pp. 1091-2. Date of Electronic Publication: 2014 Jan 10.
Publication Year :: 2014
Abstract: Some comments have been done on an article describing a pilot trial evaluating the potential use of moxidectin contained in a spot-on formulation in the prevention of canine filarioses in a confined area where the three major canine filariae live in sympatry. We herein present our response to these comments.

Subjects :: Animals
Antinematodal Agents therapeutic use
Dog Diseases drug therapy
Dog Diseases prevention & control
Filariasis drug therapy
Filariasis prevention & control
Imidazoles therapeutic use
Macrolides therapeutic use
Nitro Compounds therapeutic use

Full Text Access

Tools